Product launch puts Blackbaud stock in focus

Blackbaud (BLKB) stock is drawing attention after the company introduced a Chart of Accounts Health Advisor for Financial Edge NXT, an embedded tool that evaluates nonprofit finance data and suggests account structure improvements.

The new advisor tool is landing at a time when Blackbaud’s short term momentum has picked up, with a 1 day share price return of 2.37% and 7 day share price return of 3.14%. This sits against a weaker backdrop, including a 30 day share price return down 6.63% and a year to date share price return down 53.61%, while the 1 year total shareholder return is down 56.87%. This points to interest around product updates alongside a longer period where sentiment has cooled.

If you are looking beyond Blackbaud for ideas in software and technology, this could be a useful moment to scan 49 AI infrastructure stocks

With Blackbaud stock down sharply over the past year yet trading at a discount to analyst price targets and some intrinsic value estimates, is the recent product momentum a chance to buy, or a sign that markets already see future growth?

Most Popular Narrative: 45.9% Undervalued

Blackbaud’s most followed narrative pegs fair value at $51, well above the last close at $27.61. This puts the new product launch into a valuation context that many investors will want to understand.

Aggressive and ongoing investments in product innovation, particularly in generative and Agentic AI, are expected to drive new monetizable offerings over the next year (including separately priced AI products like a virtual fundraiser), supporting incremental revenue streams and margin expansion from high-value software.

Curious what kind of earnings and revenue path needs to sit behind that $51 figure? The narrative leans on steady growth, firmer margins and a future earnings multiple that differs sharply from today’s pricing. Want to see exactly how those pieces are stitched together into a single fair value story?

Result: Fair Value of $51 (UNDERVALUED)

However, Blackbaud’s story still carries clear risks, including pressure from larger software rivals and the possibility that nonprofit tech budgets remain tight for longer.

Next Steps

With sentiment on Blackbaud clearly mixed, this is the moment to move quickly, review the data yourself, and weigh both sides of the story using the 5 key rewards and 1 important warning sign

Looking for more investment ideas beyond Blackbaud?

If Blackbaud has sharpened your interest in fresh opportunities, do not stop here. Broaden your watchlist with curated stock ideas tailored to different investing goals.

• Target potential mispricings across the market by scanning the 44 high quality undervalued stocks for companies that may be trading below their fundamentals.
• Prioritise capital strength and resilience by reviewing the solid balance sheet and fundamentals stocks screener (48 results) for businesses with sturdier financial footing.
• Hunt for future standouts early by using the screener containing 18 high quality undiscovered gems before others catch on to their potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.